BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17312160)

  • 21. Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling.
    Hidmark AS; Nordström EK; Dosenovic P; Forsell MN; Liljeström P; Karlsson Hedestam GB
    J Virol; 2006 Jul; 80(14):7100-10. PubMed ID: 16809315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism.
    Stockinger S; Reutterer B; Schaljo B; Schellack C; Brunner S; Materna T; Yamamoto M; Akira S; Taniguchi T; Murray PJ; Müller M; Decker T
    J Immunol; 2004 Dec; 173(12):7416-25. PubMed ID: 15585867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
    Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
    J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis.
    Weighardt H; Kaiser-Moore S; Schlautkötter S; Rossmann-Bloeck T; Schleicher U; Bogdan C; Holzmann B
    J Immunol; 2006 Oct; 177(8):5623-30. PubMed ID: 17015750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-β, but not IFN-α, is Responsible for the Pro-Bacterial Effect of Type I Interferon.
    Shaabani N; Vartabedian VF; Nguyen N; Honke N; Huang Z; Teijaro JR
    Cell Physiol Biochem; 2021 May; 55(3):256-264. PubMed ID: 33984198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS; Sher A
    J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice.
    Kamijo R; Shapiro D; Gerecitano J; Le J; Bosland M; Vilcek J
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1332-8. PubMed ID: 7705746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas.
    Garcia I; Miyazaki Y; Marchal G; Lesslauer W; Vassalli P
    Eur J Immunol; 1997 Dec; 27(12):3182-90. PubMed ID: 9464804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production.
    Mahieu T; Park JM; Revets H; Pasche B; Lengeling A; Staelens J; Wullaert A; Vanlaere I; Hochepied T; van Roy F; Karin M; Libert C
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2292-7. PubMed ID: 16455798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection.
    Svensson A; Bellner L; Magnusson M; Eriksson K
    J Reprod Immunol; 2007 Jun; 74(1-2):114-23. PubMed ID: 17092567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-4 suppresses dendritic cell response to type I interferons.
    Sriram U; Biswas C; Behrens EM; Dinnall JA; Shivers DK; Monestier M; Argon Y; Gallucci S
    J Immunol; 2007 Nov; 179(10):6446-55. PubMed ID: 17982033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.
    Hedges JF; Robison A; Kimmel E; Christensen K; Lucas E; Ramstead A; Jutila MA
    Infect Immun; 2016 Jun; 84(6):1815-1825. PubMed ID: 27068091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor.
    Kamijo R; Shapiro D; Le J; Huang S; Aguet M; Vilcek J
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6626-30. PubMed ID: 8341679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type I interferon signaling and B cells maintain hemopoiesis during Pneumocystis infection of the lung.
    Meissner N; Rutkowski M; Harmsen AL; Han S; Harmsen AG
    J Immunol; 2007 May; 178(10):6604-15. PubMed ID: 17475892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages.
    Cho YC; Kim HJ; Kim YJ; Lee KY; Choi HJ; Lee IS; Kang BY
    Int Immunopharmacol; 2008 Apr; 8(4):567-73. PubMed ID: 18328448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.
    Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the involvement of type I interferon in pulmonary arterial hypertension.
    George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA
    Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.